Current recommendations for the treatment of hypertension: Are they still valid?

Journal of Hypertension

Volumn 20, Issue SUPL. 1, 2002, Pages

  Moser, Marvin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Recommendations; Therapy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOSINOPRIL; GLUCOSE; IRBESARTAN; ISRADIPINE; LIPID; LOSARTAN; NIFEDIPINE; NITRENDIPINE; VERAPAMIL;

ALPHA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG CHOICE; DRUG EFFICACY; DRUG MECHANISM; ELDERLY CARE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; META ANALYSIS; MICROALBUMINURIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; STROKE; SWEDEN; UNITED KINGDOM;

EID: 0036464234     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200212000-00001     Document Type: Conference Paper

References (32)

1. Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The sixth report
2. 1999 Guidelines for the management of hypertension
3. An overview of the meta-analyses of the hypertension treatment trials
4. Morbidity and mortality in the placebo-controlled European Trial on Isolated Systolic Hypertension in the Elderly
5. Suppositions and speculations - Their possible effects on treatment decisions in the management of hypertension
6. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)
7. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program: 1. Reduction in mortality of persons with high blood pressure, including mild hypertension
8. Antihypertensive medicatiions: Relative effectiveness and adverse reactions
9. The treatment of hypertension in diabetic patients
10. Antihypertensive drug therapy and regression of left ventricular hypertrophy: A review with a focus on diuretics
11. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: Comparison of six antihypertensive agents
12. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension
13. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease
14. Is it time for a new approach to the initial treatment of hypertension?
15. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness
16. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
17. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study
18. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
19. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
20. Randomised trial of effects of calcium antagonists compared with diuretics and B-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
21. Outcome results of the Fosinopril Versus Amlodipine Cardiovasclar Events Randomized Trial (FACET) in patients with hypertension and NIDDM
22. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
23. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (Midas)
24. Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
25. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and the MICRO HOPE substudy
26. Health outcomes associated with calcium channel antagonists compared with other first-line antihypertensive therapies: A metaanalysis of randomized controlled trials
27. Calcium antagonists: Not appropriate as first-line antihypertensive agents
28. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
29. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
30. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes